Members of Michigan State University (MSU) Institutional Review Boards (IRB), including alternates, are nominated by deans and others and appointed by the MSU Institutional Official (IO). Nominations to the IO should include a description of the individual’s qualifications and a copy of their curriculum vitae or resume.
The Michigan State University Institutional Review Boards are comprised of members affiliated with and not affiliated with MSU, and at least one member whose primary concerns are in scientific areas and at least one member whose primary concerns are in nonscientific areas.
Members of the IRBs will be recruited and added to ensure proper membership according to the U.S. Office for Human Research Protections (OHRP) and the U.S. Food and Drug Administration (FDA) that may include:
Minimum of 5 members and a maximum of 25 primary members
Diverse scientific and clinical expertise
Scientific members from appropriate disciplines (e.g., behavioral, medical)
Diversity of members, including race, gender, and cultural backgrounds and sensitivity to such issues as community attitudes
Community representation
Non-scientist representation
One or more individuals who are knowledgeable about and experienced in working with subjects who may be vulnerable to coercion or undue influence, such as children, prisoners, individuals with impaired decision-making capacity, or economically or educationally disadvantaged persons
One or more individuals who are knowledgeable about and experienced in working with vulnerable subjects, such as children, prisoners, pregnant women, or physically or mentally disabled persons
Affiliated members
Non-affiliated members
Appropriate representation from colleges or partner institutions
When appropriate the following types of individuals may be desirable for membership:
Attorney
Statistician or epidemiologist
Spiritual leaders
Ethicist
A member is considered affiliated if they or a member of their immediate family is a full or part-time employee (or has an adjunct appointment) of MSU. A member is also considered affiliated if they or a member of their immediate family is affiliated with MSU on a basis other than employment or faculty appointment, such as consultant, student, retiree, or former employee. A member is considered not to be affiliated if they are not otherwise affiliated with MSU and are not part of the immediate family of a person who is affiliated with MSU. 45 CFR 46.107(d), 21 CFR 56.107(d).
Alternate members may be appointed as needed for primary member(s). The appointment of alternate member(s) should be based on expertise similar to that of the primary member(s). If a primary member has an alternate, the rosters shall indicate such designation. An alternate member may vote at a convened IRB meeting only when the primary member is not voting. Alternate members may be assigned as expedited reviewers on research studies. When alternates substitute for a primary member, the alternate member receives and reviews the same material that the primary member received or would have received.
The composition of the IRB will be periodically evaluated and appropriate adjustments in membership and composition will be made. See Human Research Protection Program (HRPP) Manual 3-3 “Evaluation and Quality Improvement” for the evaluation process.
Other persons may be called upon for their expertise to consult for the IRB in reviews and analysis, but these persons may not vote unless they are formal members of the IRB. See HRPP Manual 5-4 “Additional Expertise” for policies and procedures.
Individuals involved in business development for the university may not serve as IRB members and may not be involved in the day-to-day operations of the review process.
The HRPP director and/or manager will report changes in the composition of the IRB to OHRP and the FDA (via OHRP). This will be done by submitting an updated roster through OHRP’s electronic renewal/update process.
Members shall be appointed for up to a three year term. Reappointments are made by the IO. There is no limit to the number of terms an individual may serve, but it is suggested that a member serve two terms and then rotate terms with other individuals. If a member wishes to continue service, a recommendation is made to the IO for reappointment.
The IO may remove a member from the IRB before the end of their appointed term. The IRB chair in consultation with the HRPP director may submit a request for removal to the IO based on the member’s failure to carry out the responsibilities of an IRB member (e.g. failure to attend meetings regularly, failure to comply with regulations and policies). The IO makes the final decision on removals. If removed, prompt notification will be provided to the member. IRB members may request to be removed from the IRB without providing a reason (e.g. time commitment, personal reasons) and will be removed with notification to the IO. Efforts will be made when possible to retain the IRB member so that the three year term may be completed.
The regulations state that only “experienced reviewers designated by the chairperson from among members of the IRB” may conduct expedited reviews. 45 CFR 46.110(b), 21 CFR 56.110(b). To be designated as an “experienced” IRB member, the IRB chair will evaluate the IRB member in light of:
Completion of the orientation process
Involvement in several studies as a shadow reviewer (see HRPP Manual 11-1-B “Education: IRB Members” for a description of shadow review)
Involvement in the review of convened IRB studies
Attendance and thoughtful contributions at six or more convened meetings
Previous IRB experience, if any
The IRB chair will determine whether the member is experienced, in terms of professional competence, or if further experience is needed. If the IRB member is deemed as experienced, the IRB chair shall notify the IRB member in writing of the determination. If the IRB member is not deemed to be experienced, additional training will be required as appropriate. The IRB chair will determine which members designated as experienced may conduct reviews using expedited procedures.
The IRB chair, with input from appropriate administrators, provides information to the HRPP director and/or the IO for evaluation of IRB members. See HRPP Manual 3-3 “Evaluation and Quality Improvement” for the evaluation process.
IRB members shall:
Uphold federal, state, and local regulations, university policies and procedures, and ethical standards for the protection of human research subjects.
Attend and contribute to discussion at IRB meetings.
Review IRB meeting materials prior to the IRB meeting.
Perform review of studies as assigned.
Act as lead reviewer on full review studies as assigned, including:
Provide a summary of review (including reviewer comments).
Present results of reviews at IRB meetings.
Review application materials based on federal regulations, state law, and university policies.
Review studies applying current HRPP policies and procedures.
Provide timely written or electronic feedback on all application materials assigned. Timeliness is based upon the deadline provided as part of the particular review assignment.
Disclose conflict(s) of interest pursuant to the policy and procedures in HRPP Manual 10-1 “Conflict of Interest.”
Communicate with researchers as needed.
Communicate with their departments or partner institutions and provide updates concerning IRB activities as appropriate.
Participate in activities to enhance development as an IRB member, such as:
Continuing education on human research activities.
Evaluation processes.
Provide guidance and assistance on matters such as maintaining accreditation by the Association for the Accreditation of Human Research Protection Programs, Inc.
Participate in site visits if needed.
This policy and procedure supersedes those previously drafted.
Approved By: Vice President of Research and Graduate Studies, 4-21-2005. Revision 1 approved by VP Research & Graduate Studies on 11-2-2005. Revision 2 approved by VP Research & GraduateStudies on 2-1-2006. Revision 3 approved by VP Research & Graduate Studies on 3-9-2008. Revision 4 approved by VP Research & Graduate Studies on 1-11-2010. Revision 5 approved by VP Research & Graduate Studies on 7-21-2011. Revision 6 approved by Assistant VP Regulatory Affairs on 12-9-2015. Revision 7 approved by Assistant VP Regulatory Affairs on 12-7-2021.